Search Results - "Grishina, Elena A"

Impact of CYP2D6 Polymorphism on Equilibrium Concentration of Fluoxetine in Patients Diagnosed With Major Depressive Disorder and Comorbid Alcohol Use Disorders by Zastrozhin, Mikhail S., Skryabin, Valentin Y., Petukhov, Alexey E., Pankratenko, Ekaterina P., Grishina, Elena A., Ryzhikova, Kristina A., Torrado, Marco V., Shipitsyn, Valery V., Bryun, Evgeny A., Sychev, Dmitry A.

Get full text

Using the CYP3A Activity Evaluation to Predict the Efficacy and Safety of Diazepam in Patients With Alcohol Withdrawal Syndrome by Skryabin, Valentin Yu, Zastrozhin, Mikhail S., Grishina, Elena A., Ryzhikova, Kristina A., Shipitsyn, Valery V., V. Barna, Ilya, Galaktionova, Tatiana E., Ivanov, Andrey V., Sorokin, Alexander S., Bryun, Evgeny A., Sychev, Dmitry A.

“…Background: Diazepam is one of the most commonly prescribed tranquilizers for the therapy of alcohol withdrawal syndrome (AWS). Despite its popularity, there…”
Get full text

Effects of CYP2C192 polymorphisms on the efficacy and safety of phenazepam in patients with anxiety disorder and comorbid alcohol use disorder by Zastrozhin, Michael S., Skryabin, Valentin Y., Torrado, Marco, Petrovna, Anastasiya, Sorokin, Alexander S., Grishina, Elena A., Ryzhikova, Kristina A., Bedina, Inessa A., Buzik, Oleg Z., Chumakov, Egor M., Savchenko, Ludmila M., Brun, Evgeny A., Sychev, Dmitry A.

“…© 2020 Future Science Group. Introduction: Phenazepam therapy can often be ineffective and some patients develop dose-related adverse drug reactions. Aim. The…”
Get full text

Role of Inflammatory Mediators, Growth Factors, and Osteodystrophy in Recurrent Lumbar Disk Herniation by Chekhonatskiy, Vladimir A., Dreval, Oleg N., Kuznetsov, Aleksei V., Chekhonatskiy, Andrey A., Zakharova, Natalya B., Grishina, Elena A., Gorozhanin, Aleksandr V., Volna, Vera V.

“…Introduction. Reintervention in patients with spinal disk herniation is shown to significantly decrease likelihood of favorable outcomes in the postoperative…”
Get full text

Using a personalized clinical decision support system for bromdihydrochlorphenylbenzodiazepine dosing in patients with anxiety disorders based on the pharmacogenomic markers by Zastrozhin, Michael S., Sorokin, Aleksandr S., Agibalova, Tatyana V., Grishina, Elena A., Antonenko, Anastasiya Р., Rozochkin, Ilya N., Duzhev, Denis V., Skryabin, Valentine Y., Galaktionova, Tatyana E., Barna, Ilya V., Orlova, Anna V., Aguzarov, Albert D., Savchenko, Ludmila M., Bryun, Evgeny A., Sychev, Dmitry A.

“…Introduction Although pharmacogenetic tests provide the information on a genotype and the predicted phenotype, these tests themselves do not provide the…”
Get full text

Evaluation of the association of polymorphisms of the CYP2C8 gene with the efficacy and safety of ketorolac in patients with postoperative pain syndrome by Muradian, Andranik A., Sychev, Dmitry A., Blagovestnov, Dmitry A., Petrov, Demyan I., Skukin, Dmitry S., Epifanova, Irina P., Sozaeva, Zhannet A., Kachanova, Anastasia A., Denisenko, Natalia P., Abdullaev, Sherzod P., Grishina, Elena A.

“…Aim. To evaluate the possible association of CYP2C8 gene polymorphisms with the clinical efficacy and safety of ketorolac in relation to postoperative pain…”
Get full text

CYP2C8, PTGS-1, 2 gene polymorphisms prevalence associated with sensitivity to non-steroidal anti-inflammatory drugs among North Caucasus ethnic groups by Abdullaev, Sherzod P., Denisenko, Natalia P., Mirzaev, Karin B., Shuev, Gregorii N., Sozaeva, Zhannet A., Kachanova, Anastasia A., Mammaev, Suleiman N., Kasaeva, Elvira A., Gafurov, Danial M., Grishina, Elena A., Sychev, Dmitry A.

“…Aim. Find the prevalence of CYP2C8*3 (rs10509681; rs11572080), PTGS-1 (rs10306135; rs12353214) and PTGS-2 (rs20417) alleles and genotypes in four ethnic groups…”
Get full text

Antihypertensive Effect Of Amlodipine In Co-Administration With Omeprazole In Patients With Hypertension And Acid-Related Disorders: Cytochrome P450-Associated Aspects by Dorofeeva, Margarita N, Shikh, Evgenia V, Sizova, Zhanna M, Tarasenko, Alisa V, Denisenko, Natalia P, Smirnov, Valeriy V, Ryzhikova, Kristina A, Sozaeva, Zhannet A, Grishina, Elena A, Sychev, Dmitriy A

“…CYP2C19 and CYP3A are the main enzymes involved in omeprazole metabolism, while CYP3A is the principal enzyme family for amlodipine biotransformation…”
Get full text

CYP3A and CYP2C19 activity in urine in relation to CYP3A4, CYP3A5, and CYP2C19 polymorphisms in Russian peptic ulcer patients taking omeprazole by Denisenko, Natalia P, Sychev, Dmitriy A, Sizova, Zhanna M, Smirnov, Valeriy V, Ryzhikova, Kristina A, Sozaeva, Zhannet A, Grishina, Elena A

“…Proton pump inhibitors (PPIs) are metabolized by cytochrome P450. CYP2C19 is the main isoenzyme for the majority of PPI, whereas CYP3A family is a secondary…”
Get full text

Urine metabolic ratio of omeprazole in relation to CYP2C19 polymorphisms in Russian peptic ulcer patients by Denisenko, Natalia P, Sychev, Dmitriy A, Sizova, Zhanna M, Smirnov, Valeriy V, Ryzhikova, Kristina A, Sozaeva, Zhannet A, Grishina, Elena A

“…CYP2C19 is known to be the main enzyme of biotransformation of proton pump inhibitors (PPIs), whereas the gene is highly polymorphic. Genotyping and…”
Get full text

Do CYP2C19 and ABCB1 gene polymorphisms and low CYP3A4 isoenzyme activity have an impact on stent implantation complications in acute coronary syndrome patients? by Rytkin, Eric, Mirzaev, Karin B, Grishina, Elena A, Smirnov, Valeriy V, Ryzhikova, Kristina A, Sozaeva, Zhannet A, Giliarov, Michael Iu, Andreev, Denis A, Sychev, Dmitriy A

“…The aim of this study was to determine the impact of and gene polymorphisms and CYP3A4 isoenzyme activity on stent implantation complications among patients…”
Get full text

EJECTION PRESSURE LOCK CHARACTERISTICS AND CALCULATION by Evgeny K. Spiridonov, Elena A. Grishina, Alexander V. Podzerko

“…A design model and general properties of the ejection pressure lock are offered. A selection method of the pressure lock with the lowest power consumption is…”
Get full text

Hyperbaric Oxygenation in Recurrent Rectal Bleeding in the Background of Radiation Proctitis by Leontev, A. V., Levina, O. A., Grishina, E. A., Danilov, M. A., Shishin, K. V., Babkina, А. V.

“…Radiation proctitis is a complication of radiation therapy used in the treatment of pelvic malignant tumors. The leading clinical symptom of this kind of late…”
Get full text

Polymorphism 3435c> t of the ABCB1 gene (rs1045642) does not affect the mirtazapine efficiency and safety profile in patients with depressive disorders comorbid with alcohol use disorder by Zastrozhin, M. S., Grishina, E. A., Ryzhikova, K. A., Skryabin, V. Yu, Koporov, S. G., Bryun, E. A., Sychev, D. A.

“…Background. Mirtazapine is used to treat patients with depressive disorders. A large proportion of patients in this group do not adequately respond to…”
Get full text

Effects of CYP2D6 genetic polymorphisms on the efficacy and safety of fluvoxamine in patients with depressive disorder and comorbid alcohol use disorder by Zastrozhin, Mikhail Sergeevich, Grishina, Elena Anatolievna, Denisenko, Nataliya Petrovna, Skryabin, Valentin Yurievich, Markov, Dmitry Dmitrievich, Savchenko, Ludmila Mikhailovna, Bryun, Evgeny Alekseevich, Sychev, Dmitry Alekseevich

“…Fluvoxamine therapy is used for treatment of patients with depressive disorder, but it is often ineffective, and some patients suffer from dose-dependent…”
Get full text

Effect of polymorphisms in CYP3A422 (rs35599367) C>T, CYP3A53 (rs776746) A>G, ABCB1 (rs4148738) C>T and ABCB1 (rs1045642) C>T genes on apixaban anticoagulation: pilot study results by Sychev, I. N., Fedina, L. V., Osipov, A. S., Temirbulatov, I. I., Tataroy, O. Yu, Sozaeva, Zh. A., Akmalova, K. A., Denisenko, N. P., Abdullaev, S. P., Kachanova, A. A., Grishina, E. A., Mirzaev, K. B., Sychev, D. A.

“…Introduction . Apixaban is a direct oral anticoagulant prescribed for treatment and prevention of venous thromboembolism (VTE) and for prevention of stroke in…”
Get full text

Do CYP2C 19 and ABCB1 gene polymorphisms and low CYP3A4 isoenzyme activity have an impact on stent implantation complications in acute coronary syndrome patients? by Rytkin, Eric, Mirzaev, Karin B, Grishina, Elena A, Smirnov, Valeriy V, Ryzhikova, Kristina A, Sozaeva, Zhannet A, Giliarov, Michael Lu, Andreev, Denis A, Sychev, Dmitriy A

“…Aim: The aim of this study was to determine the impact of CYP2C19 and ABCB1 gene polymorphisms and CYP3A4 isoenzyme activity on stent implantation…”
Get full text

Urine metabolic ratio of omeprazole in relation to CYP2C 19 polymorphisms in Russian peptic ulcer patients by Denisenko, Natalia P, Sychev, Dmitriy A, Sizova, Zhanna M, Smirnov, Valeriy V, Ryzhikova, Kristina A, Sozaeva, Zhannet A, Grishina, Elena A

“…Background: CYP2C 19 is known to be the main enzyme of biotransformation of proton pump inhibitors (PPIs), whereas the CYP2C19 gene is highly polymorphic…”
Get full text

Do CYP2C19 andABCB1 gene polymorphisms and low CYP3A4 isoenzyme activity have an impact on stent implantation complications in acute coronary syndrome patients? by Rytkin, Eric, Mirzaev, Karin B, Grishina, Elena A, Smirnov, Valeriy V, Ryzhikova, Kristina A, Sozaeva, Zhannet A, Michael Iu Giliarov, Andreev, Denis A, Sychev, Dmitriy A

“…Aim: The aim of this study was to determine the impact of CYP2C19 and ABCB1gene polymorphisms and CYP3A4 isoenzyme activity on stent implantation complications…”
Get full text

New Pharmacogenetic Markers to Predict the Risk of Bleeding During Taking of Direct Oral Anticoagulants by Mirzaev, K. B., Ivashchenko, D. V., Volodin, I. V., Grishina, E. A., Akmalova, K. A., Kachanova, A. A., Skripka, A. I., Minnigulov, R. M., Morozova, T. E., Baturina, O. A., Levanov, A. N., Shelekhova, T. V., Kalinkin, A. I., Napalkov, D. A., Sokolova, A. A., Andreev, D. A., Sychev, I. N., Bochkov, P. O., Sychev, D. A.

“…Aim . To search for new pharmacogenetic biomarkers of bleeding risk in patients taking rivaroxaban and dabigatran for different indications: atrial…”
Get full text